The whistleblower whose actions led to a major settlement payment by GlaxoSmithKline will sleep well, knowing she did the right thing. Cheryl Eckard is also eligible to be compensated under the False Claims Act, and will receive $96 million of the $750 million the British pharmaceutical giant has agreed to pay.
GSK will pay the settlement amount and plead guilty to one criminal charge due to manufacture of adulterated drugs in its Puerto Rico facility. The charges focused on the drugs manufactured at GSK's plant in Cidra, Puerto Rico,The Wall Street Journal reports. From 2001 to 2005, the anti-depressants made there were found by federal authorities to have been prepared with incorrect amounts of the active ingredient or would split apart, posing a safety risk to patients taking the medication.